-- Teva Rises to Five-Month High on U.S.-Traded Shares Advance
-- B y   S h o s h a n n a   S o l o m o n
-- 2011-12-18T14:53:09Z
-- http://www.bloomberg.com/news/2011-12-18/teva-rises-to-five-month-high-on-u-s-traded-shares-advance.html
Teva Pharmaceutical Industries Ltd. (TEVA) ,
the world’s largest maker of generic drugs, climbed to the
highest level in almost five months following an increase in its
U.S.-traded stock.  The shares in the Petach-Tikva, Israel-based company rose
to the highest level since July 20, gaining 2.8 percent to
162.90 shekels, or the equivalent of $42.89, at the 4:30 p.m.
close in  Tel Aviv . Teva’s U.S.-traded shares closed at $42.72 on
Dec. 16.  Teva has declined 12 percent in Tel Aviv this year.  To contact the reporter on this story:
Shoshanna Solomon in Tel Aviv at 
 ssolomon22@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  